Médicaments (7 lots)

This tender for medicinal products is generally well-structured with clear documentation and a reasonable process, though it lacks specific details on evaluation criteria and sustainability aspects.

The tender adheres to EU procurement directives (2014/24/ES) and uses the correct CPV code. The procedure is open, and the organization is a central government authority. While deadlines are present, the submission deadline might be considered short given the complexity of the tender (7 parts). No disputes are indicated. The lack of specified evaluation criteria is a minor concern for legal compliance regarding transparency.

The tender title and description are clear, indicating the procurement of medicinal products in 7 parts. Key documents like the contract notice, special conditions, and ESPD are provided. However, the absence of explicit technical, financial, and eligibility requirements in the AI-extracted section means bidders must rely heavily on the attached documents for full clarity.

Most basic information is present, including the title, reference, organization, and contract duration. The tender is divided into 7 parts, and EU funding is indicated. However, the estimated value is not disclosed, which is a significant omission. The AI-extracted requirements are also missing, impacting the completeness of the initial overview.

The tender is an open procedure, suggesting a fair process. The use of e-procurement is positive. The division into 7 parts allows for broader participation. However, the lack of disclosed estimated value and the absence of specified evaluation criteria could be perceived as less transparent, although no specific company tailoring is evident.

The tender utilizes e-procurement, which is a positive aspect for submission. The contract duration of 36 months is specified. However, the AI-extracted section does not confirm e-submission details or financing information beyond 'EU Funded'. The contract start date is not explicitly stated, and the deadline might be tight for preparing comprehensive bids for 7 parts.

Key fields such as title, reference, organization, and CPV code are populated. The tender is active, and no disputes are reported. Dates are logically presented, with an opening date following the submission deadline. The contract duration is consistent. The lack of estimated value is noted but does not create logical inconsistencies within the provided data.

The tender is marked as 'EU Funded', which often implies adherence to certain standards, but specific green procurement, social aspects, or innovation criteria are not explicitly mentioned or detailed in the provided information. This suggests a moderate focus on sustainability.